IVIG Treatment and Prognosis in Guillain–Barré Syndrome

INTRODUCTION: Guillain–Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that often leads to severe weakness. Intravenous immunoglobulin (IVIG) is a proven effective treatment for GBS (class 1 evidence). However, about 25% of patients need artificial ventilation and 20% are still unab...

Descripción completa

Detalles Bibliográficos
Autores principales: van Doorn, Pieter A., Kuitwaard, Krista, Walgaard, Christa, van Koningsveld, Rinske, Ruts, Liselotte, Jacobs, Bart C.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883091/
https://www.ncbi.nlm.nih.gov/pubmed/20396937
http://dx.doi.org/10.1007/s10875-010-9407-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883091/
https://www.ncbi.nlm.nih.gov/pubmed/20396937
http://dx.doi.org/10.1007/s10875-010-9407-4

Ejemplares similares